Placebo - film-coated tablets, Lynparza 100 mg film-coated tablets, Lynparza 150 mg film-coated tablets
SOLO 1-D0818C00001
Phase 3 small_molecule active
Quick answer
Placebo - film-coated tablets, Lynparza 100 mg film-coated tablets, Lynparza 150 mg film-coated tablets for BRCA Mutated Advanced (FIGO Stage III-IV) Ovarian Cancer is a Phase 3 program (small_molecule) at AstraZeneca AB with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca AB
- Indication
- BRCA Mutated Advanced (FIGO Stage III-IV) Ovarian Cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active